Maryia Zhdanava

The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States

Maryia Zhdanava, Dominic Pilon, Isabelle Ghelerter et al. · The Journal of Clinical Psychiatry · 2021 · 487 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +16

Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis

Geneviève Gauthier, Annie Guérin, Maryia Zhdanava et al. · BMC Psychiatry · 2017 · 68 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions

Maryia Zhdanava, Harsh Kuvadia, Kruti Joshi et al. · Journal of Managed Care & Specialty Pharmacy · 2020 · 25 citations · Full text

Pharmacy, Pharmacoeconomics, Psychiatry +13

Prevalence, incidence and economic burden of schizophrenia among Medicaid beneficiaries

Dominic Pilon, Charmi Patel, Marie‐Hélène Lafeuille et al. · Current Medical Research and Opinion · 2021 · 25 citations

Medicine, Health Sciences, Psychiatry +17

Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?

Dominic Pilon, John J. Sheehan, Holly Szukis et al. · Journal of Affective Disorders · 2019 · 22 citations · Full text

Pharmacy, Pharmacoeconomics, Psychiatry +17